IGF2BP2 and hepatocellular carcinoma: Our observations suggest that m6A methylation facilitates IGF2BP2 binding to GAS5, enhancing its stability, and confirm significant overexpression of GAS5 in large cohorts of patients with HCC (Fig. 2a).